29 June 2016
IPA Meeting with the FDA: Quality Forum Update, Washington DC.
13 May 2016
Presentation to IGDRP: Licensing of Generic Products: Needs and Expectation of Industry, Strasbourg.
13 April 2015
IPA Meeting with the FDA: Desire to Work Together, Washington DC.
6 May 2015
Presentation to Health Secretary: TRIPS article 39.3 & Data Exclusivity, New Delhi.
17 November 2015
IPA Meeting with the FDA: Quality Forum, Washington DC.
12 December 2014
CII-12th National Pharmaceutical Conclave 2014: Industry Perspective, New Delhi.
7 August 2014
Improving Access; Promoting Innovation: Access to Medicines & Universal Health Coverage, Chennai.
4 July 2014
IPA-FDA Workshop - May 2014 Effective Quality Systems: Participants' Feedback, Mumbai.
6 March 2014
National Conference on Pharmaceutical Policies in India Balancing Industrial and Public Health Interests Drug Pricing: Implication of DPCO 2013, New Delhi.
29 November 2013
GoM: Impact Assessment of NPPP 2012, New Delhi.
21 November 2012
GoM_NPPP 2011: Road Map for Carefully Calibrated Policy to Avoid Adverse Trade Offs, New Delhi.
18 March 2012
Roundtable Symposium on The Emerging Legal & Policy Landscape of IP Protection for Pharmaceuticals in India: NPPP 2011, Jodhpur.
15 January 2012
Roundtable Meeting with Secretary - US Department of HHS: Indian Pharmaceutical Industry, Mumbai.